Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 11, 2020 16:10 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics and Takeda Pharmaceutical Complete Feasibility Study

MEDFORD, N.Y., March 11, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it...
March 03, 2020 17:42 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020

MEDFORD, March 03, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release...
March 03, 2020 08:30 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Provides Update on Regulatory Status of DPP HIV-Syphilis System

MEDFORD, N.Y., March 03, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, is providing an update on the...
February 12, 2020 07:45 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Receives $1.5 Million UNICEF Order for Multiplex Zika Systems

MEDFORD, N.Y., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced a $1.5 million...
January 09, 2020 16:05 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Announces CEO Transition

MEDFORD, N.Y., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced President and...
January 02, 2020 16:05 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Provides Update on FDA Submission of DPP HIV-Syphilis Test

MEDFORD, N.Y., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today provided an update on its...
November 25, 2019 16:30 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Completes Acquisition of Orangelife

MEDFORD, N.Y., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it has...
November 14, 2019 16:40 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics to Participate in Upcoming Investor Conferences

MEDFORD, N.Y., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today the company...
November 07, 2019 16:05 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Reports Third Quarter 2019 Financial Results

MEDFORD, N.Y., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial...
November 07, 2019 16:03 ET | Source: Chembio Diagnostics, Inc.

Chembio Diagnostics Enters into Definitive Agreement to Acquire Orangelife

Acquisition will expand commercial presence and market opportunity in Brazil MEDFORD, N.Y., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care...